Xcellerex's Series B Round

Xcellerex raised a round of funding on January 24, 2007. Investors include Kleiner Perkins Caufield & Byers.

Xcellerex aims to develop, manufacture and commercialize biomolecules. Xcellerex is built around a biomanufacturing platform that features the application of single-use component technology. The Xcell…

Articles about Xcellerex's Series B Round: